1. Disease and acetylation polymorphism;Lunde;Clin Pharmacokinet,1977
2. Relationship of acetyl transferase activity to antinuclear antibodies and toxic symptoms in hypertensive patients treated with hydralazine;Perry;J Lab Clin Med,1970
3. Hydralazine elimination in man;Reidenberg;Clin Pharmacol Ther,1973
4. Hydralazine kinetics after single and repeated oral doses;Shepherd;Clin Pharmacol Ther,1980
5. Late toxicity to hydralazine resembling systemic lupus erythematosus or rheumatoid arthritis;Perry;Am J Med,1973